References
- Andreasen N. Thought, language and communication disorders. Arch Gen Psychiatry 1979; 36: 1315–1321
- Wijeratne C, Sachdev P. Treatment-resistant depression: critique of current approaches. Aust N Z J Psychiatry 2008; 42: 751–762
- Ban TA, Guy W, Wilson WH. Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenia patients. Can J Psychiatry 1985; 30: 406–408
- Metelitsa AI, Nguyen GK, Lin AN. Imipramine-induced facial pigmentation: case report and literature review. J Cutan Med Surg 2005; 9: 341–345
- Moller HJ. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1101–1111
- Sanofi Aventis Australia. Amisulpride product information, solian tablets and solution. Macquarie Park: Sanofi Aventis Australia, 2007.
- Borras L, Huguelet P. A case report of photosensitivity to amisulpride. Prim Care Companion J Clin Psychiatry 2007; 9: 153